HDAC9 and cancer: To learn more about BET/BRD inhibitors in translational neuroscience is furthermore important, taken into account that drugs which inhibit a related class of proteins, namely HDAC inhibitor, are already used in cancer treatment and also provide suitable drug targets to treat neurodegenerative diseases.3 Data on BET/BRD inhibitors and memory function are however rare and conflicting.